LKB1 loss in melanoma disrupts directional migration toward extracellular matrix cues

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Somatic STK11/LKB1/PAR-4 gene inactivation occurs in various cancers, notably ~10% of melanomas.
• The precise mechanisms by which LKB1 loss drives melanoma invasion and metastasis are not fully elucidated.
• Understanding LKB1's role is crucial for developing targeted melanoma therapies.

Purpose of the Study:

• To investigate the mechanism underlying LKB1 loss-induced increase in melanoma invasive motility.
• To determine LKB1's function in sensing extracellular matrix gradients versus soluble growth factor gradients.
• To identify the specific LKB1-regulated pathways involved in melanoma cell migration.

Main Methods:

• Utilized LKB1-null and reconstituted murine melanoma cell lines.
• Employed a microfluidic gradient chamber system and time-lapse microscopy.
• Performed systematic perturbation of known LKB1 effector kinases, including AMPK and MARK/PAR-1.

Main Results:

• Uncovered a novel function of LKB1 as a directional sensor of extracellular matrix gradients (haptotaxis), but not soluble cues (chemotaxis).
• Demonstrated that LKB1's role in haptotaxis does not require canonical AMPK activity.
• Identified the AMPK-related microtubule affinity-regulating kinase (MARK)/PAR-1 family kinases as essential for this LKB1-mediated sensing.
• Showed that inhibiting the LKB1-MARK pathway enhances invasive motility.

Conclusions:

• LKB1 functions as a critical sensor of haptotactic cues, guiding melanoma cell migration.
• The LKB1-MARK/PAR-1 pathway, independent of AMPK, mediates this sensing function.
• Loss of LKB1 function may promote melanoma invasion by impairing the ability to sense inhibitory matrix cues.